Ropivacaine and Lidocaine

PreclinicalSmall molecule

LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Ropivacaine and Lidocaine is one of 3 small molecule programs targeting Local. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

LocalNot yet recruiting

LocalPreclinical

Not yet recruiting

Competition

Competitive Landscape

3 competitors in Local

#DrugCompanyPhaseTrials

Growth Hormone

Pfizer

Preclinical

1 2

L-NMMA

NNational Heart, Lung, and Blood Institute (NHLBI)

Preclinical

1 3

Ropivacaine and Lidocaine

LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2027

N/ANot yet recruiting

Local

NCT06671028

Clinical

Trials by Indication[1]

Local1 trial

Mixed Local for Sciatic Block

Not yet recruiting·LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's·N/A·NCT06671028·110 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Ropivacaine and Lidocaine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Ropivacaine and Lidocaine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Ropivacaine and Lidocaine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: LLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Ropivacaine and Lidocaine

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2027

Trials by Indication[1]

Local1 trial

References

Drug Info

Quick Facts

Related News